Cancer patients get a tailored Stop-Smoking boost
NCT ID NCT06218823
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This study tested two smoking cessation treatments in 52 adults diagnosed with cancer in the past 3 years. One group received varenicline (a pill) plus 7 counseling calls focused on cancer; the other got nicotine patches plus 3 standard counseling calls. The goal was to see which approach helps more patients stay smoke-free 26 weeks after quitting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UW Carbone Cancer Center
Madison, Wisconsin, 53792, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Varenicline and nicotine patch
What this could lead to
If successful, this could show which smoking cessation approach works best for cancer patients, helping them quit and improve their health.
What could go wrong
This is a small pilot study with only 52 participants, so results may not apply to all cancer patients. The treatments may not lead to long-term quitting.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.